| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,091 |
3,315 |
$200K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,395 |
4,125 |
$178K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,599 |
4,445 |
$154K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,014 |
4,113 |
$125K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,938 |
3,169 |
$91K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,932 |
1,348 |
$62K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,060 |
773 |
$56K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
525 |
379 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
206 |
128 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
86 |
69 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
429 |
163 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
256 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
103 |
93 |
$2K |
| 0012A |
|
18 |
13 |
$313.29 |
| 0011A |
|
18 |
13 |
$175.01 |
| 87807 |
|
20 |
14 |
$158.24 |
| 81003 |
|
138 |
98 |
$109.87 |
| 91301 |
|
16 |
12 |
$0.00 |
| 99072 |
|
186 |
141 |
$0.00 |